Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.

04

Sep

Mater Research CEO appointed to new National Blood Cancer Taskforce

Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.

29

Aug

Immune infiltration 'promising tool' to improve outcomes for follicular lymphoma